In a study performed by Ma et al., it was illustrated that ML algorithms were able to accurately distinguish triple-negative breast cancer (TNBC) from other molecular subtypes, such as ER/PR-positive tumors and HER2-positive tumors. Here, ERBB2 is linked to triple-negative breast carcinoma.